About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Quantification of Respiratory-induced Prostate Motion

NCT00980993·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Oregon Health and Science University

Age

18–any

Sex

MALE

Healthy volunteers

Not accepted

You may be eligible if

Histologically confirmed stage I-III adenocarcinoma of the prostate gland
Age \> 18 years. Males of all races and ethnic groups
Scheduled to receive radiation for definitive therapy
Three (3) electromagnetic transponders implanted into prostate gland

The record

StatusWithdrawn

PhaseNo phase

Taking part0

StartedSep 2012

UpdatedNov 4, 2019

Conditions

Prostate Cancer

Where1

Oregon Health and Science University
Portland, Oregon, United States

Clareo Health | Quantification of Respiratory-induced Prostate Motion